Business Of Biotech cover image

The AI Impact with Generate:Biomedicines' Mike Nally

Business Of Biotech

CHAPTER

Exploring the Language of Proteins for Therapeutic Development

The chapter delves into the use of generative artificial intelligence to decode the language of proteins for creating innovative protein-based therapeutics, highlighting the shift from traditional trial and error methods. It discusses the vast potential and combinatorial possibilities in protein research and its implications for future drug development. The speaker shares insights on managing challenges in the biotech industry, emphasizing the significance of failure, interdisciplinary teamwork, and strategic business approaches for sustainable innovation.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner